How AI is helping speed up the diagnosis and treatment of stroke patients

More patients are getting the right treatment in the right place more quickly, leading to better outcomes following a stroke thanks to a four-year collaborative programme led by Health Innovation Oxford and Thames Valley (Oxford HIN) supporting the deployment of artificial intelligence (AI) in stroke diagnosis.

This approach has led to an increase in the number of stroke patients treated with mechanical thrombectomy (MT), a life-changing but time-critical intervention which reduces long-term disability following a stroke by reopening a blocked blood vessel in the brain. New image analysis technology enables high quality CT brain scans to be shared quickly and securely within and between hospitals using imaging software incorporating AI to support clinical decision-making.

Working with the NHS England stroke teams and regional stroke networks, the Oxford HIN carried out the largest real world evaluation to date of an AI tool in the NHS focusing on the impact of rolling out the Brainomix 360 Stroke AI tool. Brainomix is based in Oxford and is a University of Oxford spin-out. The evaluation was funded by the NHS Artificial Intelligence in Health and Care Award.

In a recent NHS blog and video, the transformative power of AI in stroke care was highlighted. Read the blog here, and watch the video below-

 

 

Read more from Health Innovation Oxford and Thames Valley (Oxford HIN) here. 

 

 

Recent news

Benedicts joins CBRE as joint agents for Milton Park

Benedicts joins CBRE as joint agents for Milton Park

Milton Park, the UK’s largest single ownership innovation community, has appointed Benedicts to join CBRE as joint leasing agents for the 2.8 million sq ft Park. Milton Park welcomed over 40 new occupiers in 2025 and is now home to more than 280 innovative companies....

read more
Launch of the BioEscalator Annual Review – 2024/25

Launch of the BioEscalator Annual Review – 2024/25

People and partnerships driving better patient health The BioEscalator is the University of Oxford’s thriving incubator for fast-growing biomedical companies. In 2024/25 it worked with people and organisations across the local and global innovation ecosystem and it’s...

read more
Loading...